Clinical Trials Directory

Trials / Completed

CompletedNCT01612182

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
1,289 (actual)
Sponsor
Inje University · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Conditions

Interventions

TypeNameDescription
OTHERrenal replacement therapyrenal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

Timeline

Start date
2012-03-01
Completion
2012-05-01
First posted
2012-06-05
Last updated
2012-06-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01612182. Inclusion in this directory is not an endorsement.

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy (NCT01612182) · Clinical Trials Directory